Teresa Gonzalez Gallego-rekin lankidetzan egindako argitalpenak (9)

2021

  1. Identification of a critical binding site for local anaesthetics in the side pockets of Kv1 channels

    British Journal of Pharmacology, Vol. 178, Núm. 15, pp. 3034-3048

  2. Kv1.5–kvβ1.3 recycling is pkc-dependent

    International Journal of Molecular Sciences, Vol. 22, Núm. 3, pp. 1-12

2019

  1. Corrigendum to Supplemental Material: ‘D242N, a K V 7.1 LQTS mutation uncovers a key residue for I Ks voltage dependence’ [Journal of Molecular and Cellular Cardiology, Volume 110, September 2017, Pages 61–69](S0022282817301633)(10.1016/j.yjmcc.2017.07.009)

    Journal of Molecular and Cellular Cardiology

  2. Targeting the neuronal calcium sensor DREAM with small-molecules for Huntington’s disease treatment

    Scientific Reports, Vol. 9, Núm. 1

2017

  1. D242N, a KV7.1 LQTS mutation uncovers a key residue for IKs voltage dependence

    Journal of Molecular and Cellular Cardiology, Vol. 110, pp. 61-69

  2. Fludarabine inhibits KV1.3 currents in human B lymphocytes

    Frontiers in Pharmacology, Vol. 8, Núm. MAR

  3. IKs computational modeling to enforce the investigation of D242N, a KV7.1 LQTS mutation

    Computing in Cardiology

2014

  1. PKC inhibition results in a Kv1.5 + Kvβ1.3 pharmacology closer to Kv1.5 channels

    British Journal of Pharmacology, Vol. 171, Núm. 21, pp. 4914-4926

2004

  1. Interaction of angiotensin II with the angiotensin type 2 receptor inhibits the cardiac transient outward potassium current

    Cardiovascular Research, Vol. 62, Núm. 1, pp. 86-95